Literature DB >> 155473

Neutral protease inhibitors from human intervertebral disc and femoral head articular cartilage.

J A Knight, R W Stephens, G R Bushell, P Ghosh, T K Taylor.   

Abstract

Assays of several proteases, incorporating guanidinium chloride extracts of human femoral head cartilage and intervertebral disc, demonstrated that both tissues contain inhibitors of certain serine proteases. Trypsin, chymotrypsin and a granule extract of human polymorphonuclear leukocytes containing elastase and cathepsin G activities, were inhibited by low molecular weight fractions prepared by Sephadex G-75 chromatography. Using a radioassay, it was further shown that these fractions inhibit proteolysis of cartilage proteoglycan. The inhibitor in intervertebral disc is concentrated in the nucleus pulposus, with a decreasing gradient to the periphery of the annulus fibrosus. It is proposed that these inhibitors confer at least partial protection against pathological proteolysis of the proteoglycans in human articular cartilage and nucleus pulposus.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 155473     DOI: 10.1016/0304-4165(79)90276-9

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  4 in total

1.  Study of enzyme inhibitors in the rheumatoid pannus-cartilage area.

Authors:  E D Flory; K D Muirden
Journal:  Rheumatol Int       Date:  1983       Impact factor: 2.631

2.  Avian tibial dyschondroplasia. II. Biochemical changes.

Authors:  B D Freedman; C V Gay; R M Leach
Journal:  Am J Pathol       Date:  1985-05       Impact factor: 4.307

3.  Evidence for polymorphonuclear-leucocyte-derived proteinases in arthritic cartilage.

Authors:  J D Sandy; A Sriratana; H L Brown; D A Lowther
Journal:  Biochem J       Date:  1981-01-01       Impact factor: 3.857

4.  Chondrocyte-mediated depletion of articular cartilage proteoglycans in vitro.

Authors:  J A Tyler
Journal:  Biochem J       Date:  1985-01-15       Impact factor: 3.857

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.